Advances in Inflammatory Bowel Diseases (AIBD) 2023 Annual Conference

Orlando, FL 14 December 2023 - 16 December 2023

Higher red meat intake tied to higher risk of UC flare

02 Jan 2024 by

Higher red meat intake is linked to a higher risk of ulcerative colitis (UC) flare, according to an expert who presented findings from a recent study at AIBD 2023.

Higher red meat intake tied to higher risk of UC flare

02 Jan 2024

Upadacitinib induces CD remission in patients with prior surgery

28 Dec 2023 by

Treatment with upadacitinib (UPA) delivers clinical benefits to patients with prior Crohn’s disease (CD)-related surgeries, according to a study presented at AIBD 2023. Moreover, a maintenance dose of 30 mg once a day (QD) demonstrates greater efficacy.

Upadacitinib induces CD remission in patients with prior surgery

28 Dec 2023

Risankizumab superior to ustekinumab in severe CD

27 Dec 2023 by

Risankizumab outdoes ustekinumab in achieving endoscopic remission at week 24 in patients with moderate-to-severe Crohn’s disease (CD), as well as in other clinical, endoscopic, and quality of life (QoL) outcomes, as shown by the results of the phase IIIB SEQUENCE trial presented at AIBD 2023.

Risankizumab superior to ustekinumab in severe CD

27 Dec 2023

Is histological remission feasible in UC patients?

26 Dec 2023 by

A study presented at AIBD 2023 provides strong evidence that histological remission may be achievable in patients with ulcerative colitis (UC).

Is histological remission feasible in UC patients?

26 Dec 2023

No apparent harm seen with early pregnancy ozanimod exposure, but caution still urged

23 Dec 2023 by

Exposure to ozanimod during early pregnancy does not appear to pose risks of adverse pregnancy outcomes and foetal health despite recommendations to avoid getting pregnant while receiving ozanimod and for 3 months after treatment discontinuation, according to a study.

No apparent harm seen with early pregnancy ozanimod exposure, but caution still urged

23 Dec 2023

Does appendix removal raise risk of Crohn’s disease?

22 Dec 2023 by

Individuals who have undergone an appendectomy may be at heightened risk of Crohn’s disease, according to the results of a systematic review and meta-analysis.

Does appendix removal raise risk of Crohn’s disease?

22 Dec 2023

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

22 Dec 2023 by

In an integrated analysis of two phase III ECOSPOR trials presented at AIBD 2023, faecal microbiota spores (ie, live-brpk) demonstrated favourable safety and efficacy signals for the treatment of recurrent Clostridioides (C.) difficile infection (CDI) in older individuals.

Faecal microbiota spores deliver benefit in older patients with C. diff recurrence

22 Dec 2023

Risankizumab as induction therapy induces clinical remission in UC

22 Dec 2023 by

Induction therapy with risankizumab, a monoclonal antibody neutralizing interleukin-23p19, resulted in significantly higher clinical remission rates among patients with moderate-to-severe ulcerative colitis (UC) compared with placebo, according to the INSPIRE trial presented at AIBD 2023.

Risankizumab as induction therapy induces clinical remission in UC

22 Dec 2023